Emcure Pharma: Co's Subsidiary To Buy Remaining Stake In Canada's :Mantra Pharma For CAD 50 Million (Approx. 336 Crore Rs).

Nestlé: Co. Announces Special Dividend Of Rs 2 For Each Share.

Bluspring Enterprises: Wins ₹1,437.17 Crores Operations And Maintenance Contract From Vedanta Aluminium For Captive Power Plant. Co. MCap Stands At ₹1,875 Crores.

India Accepts Chinese Companies' Participation In Essential Projects (BHEL)

Marathon NextGen Realty: Welcomes New Premium Redevelopment Project In Versova Worth Over ₹450 Crore

Bajaj Electricals: Appoints Tiny Sengupta As Chief Marketing Officer With 22 Years Of Diverse Global Experience In Healthcare And FMCG

IEX: Reports 6.3% Yearly Growth in Q1 FY’27, With June 2026 Reaching 5.4 BU in RTM, Up 25.7% Yearly

Avenue Supermarts: Goldman Sachs on Avenue Supermarts Maintains Sell with Target Price of ₹4,000 as 1QFY27 revenue growth slowed despite large store openings and higher FMCG inflation, with low store additions during the quarter, while key upside risks include faster store expansion, successful DMart Ready rollout, slower e-commerce adoption in grocery, and stronger recovery in middle-income discretionary demand.

Avenue Supermarts: Morgan Stanley on Avenue Supermarts Maintains Overweight with Target Price of ₹5,083 despite weaker-than-expected 15% sales growth after a strong 4Q, citing risks of near-term underperformance as peers sustained stronger momentum, with margins (estimated at 8%) remaining the key earnings monitor amid lower topline pressure.

Bajaj Finance: Citi on Bajaj Fin Maintains Buy with Target Price of ₹1,120 on strong 1QFY27 AUM growth (23.9% YoY, 7.2% QoQ) at the upper end of guidance, robust growth across sales finance, mortgages, gold loans, tractor, CV/CE and new car financing, 20% YoY growth in new loans to 16.13 million, 17% YoY customer franchise growth to 124.43 million, while SME lending remains cautious and the captive 2W/3W book continues to decline.

Bajaj Finance: JPM on Bajaj Fin Maintains OW, Target Price raised to ₹1,215 on strong 1Q FY27 update, driven by better-than-expected AUM growth (+7.2% QoQ, +23.9% YoY to ₹5.47 tn), record 5.1 mn new customer additions easing growth concerns, flat deposit book at ₹685 bn, and increased confidence in FY27 AUM growth at the higher end of guidance, implying upside to consensus.

Bajaj Finance: Morgan Stanley on Bajaj Finance Overweight, Target Price ₹1,120, citing above-estimate AUM growth (24% YoY), 20% loan growth, 17% customer franchise growth, strong BHFL momentum, while Q1 NIMs, credit costs and FY27 outlook remain key monitorables.

Marico: Goldman Sachs on Marico Buy, Target Price ₹900, citing accelerating double-digit volume growth led by Parachute, sustained VAHO/new business momentum, and expected high-teen EBITDA growth with sequential margin recovery.

Marico:Nomura on Marico Buy, Target Price ₹950, citing expected low-20% consolidated revenue growth, multi-quarter high double-digit India volume growth led by Parachute Coconut Oil, and strong EBITDA growth despite higher advertising and promotion spends.

Marico: HSBC on Marico Buy, Target Price ₹1,000 (raised), citing double-digit volume growth led by Parachute, 20%+ VAHO revenue growth, strong operating profit outlook, robust international performance (especially Vietnam and MENA), partly offset by softer Bangladesh demand.

Mahindra & Mahindra Financial Services: Jefferies on Mahindra & Mahindra Financial Services Hold, Target Price ₹325, citing 12.5% AUM growth, improved 21% disbursement growth, stable 95% collection efficiency, resilient asset quality with limited GS2/GS3 deterioration, but retaining Hold due to subdued growth and weak monsoon risks despite reasonable valuation.

Mahindra & Mahindra Financial Services: Citi on Mahindra & Mahindra Financial Services Buy, Target Price ₹380, citing strong Q1 disbursement growth (+21% YoY), healthy business asset growth, stable 95% collection efficiency, resilient asset quality, anchored credit costs (~2.1%) through overlays, and a strong liquidity buffer of ₹146bn.